Vaishali Pharma Share Price

Vaishali Pharma Share Price

NSE: VAISHALI
|
Pharmaceuticals
|
S Cap
₹ 8.44
+₹0.08 (0.96%)
1D
Last updated 04 Sep, 2026, 09:07 IST

Vaishali Pharma Share Price Today

As of 4 Sep 2026, Vaishali Pharma share price is ₹8.44. The stock opened at ₹8.44, compared to its previous close of ₹8.36. During today's trading session, Vaishali Pharma share price moved in the range of ₹8.44 to ₹8.44, with an average price of ₹8.44 for the day. Looking at its last 52-week, the stock has touched a low of ₹4.75 and a high of ₹12.70. On the performance front, Vaishali Pharma share price has increased by 23.12% over the last six months and is down 31.25% on a year-on-year basis.

₹8.44
0.96% up today
₹8.44
1D LOW
1D HIGH

Vaishali Pharma Returns Calculator

Circuit
L
H
₹7.53
₹9.19
52-week
L
H
₹4.75
₹12.70

About Vaishali Pharma

Vaishali Pharma Share Price
ISIN
INE972X01022
Sector Market Cap
₹ 105.15 Cr

Vaishali Pharma Limited is an India-based pharmaceutical company. The Company is in the pharmaceutical business, mainly dealing in active pharmaceutical ingredients, pharmaceutical formulations, surgical products, and veterinary supplements, operating in domestic and export markets. Its product categories include active pharmaceutical ingredients (APIs), formulation brands, formulations, herbal, nutraceutical, oncology, surgical, and veterinary. The Company has manufactured and exported approximately 250 formulations and specializes in manufacturing tailor-made formulations. It offers APIs, including antibiotics, anti-ulcer, anti-inflammatory/analgesic/ anti-pyretic, anti-malarial, cardiac, anti-diabetic, anti-cold/anti-allergic, antiviral, antifungal, skeletal muscle relaxant, and anthelmintic drugs, excipients, topical steroids, corticosteroids, and enzymes. It has a global presence in Asia & Pacific, Africa, the Commonwealth of Independent States, America, and the Middle East.

Vaishali Pharma Financial Highlights

  • Revenue: Vaishali Pharma reported revenue of ₹112.61 crore in FY26 vs ₹102.24 crore in FY25. It showed an increase of 10.14% on a yearly basis.
  • Operating Profit: Vaishali Pharma reported an operating profit of ₹5.39 crore in FY26 vs ₹1.23 crore in FY25. It showed an increase of 338.21% on a year-on-year basis.
  • Net Profit: Vaishali Pharma reported a net profit of ₹4.03 crore in FY26 vs ₹0.82 crore in FY25. It showed an increase of 391.46% on a yearly basis.

Vaishali Pharma Quarterly Result Highlights

  • Vaishali Pharma reported revenue of ₹23.47 crore in Jun 2026, compared with ₹28.19 crore in Mar 2026, representing a decrease of 16.74% on a quarter-on-quarter (QoQ) basis.
  • Vaishali Pharma reported an operating profit of ₹1.73 crore in Jun 2026, compared with ₹0.18 crore in Mar 2026, representing an increase of 861.11% on a quarter-on-quarter (QoQ) basis.
  • Vaishali Pharma reported a profit of ₹1.49 crore in Jun 2026, compared with ₹0.29 crore in Mar 2026, reflecting an increase of 413.79% on a QoQ basis.

Data Source: BSE, Company announcements

Securities shown are illustrative, not recommendations. Past performance does not guarantee future results.

Know more
Promoters
30.54%
FII
0.00%
Other DII
0.00%
Retail and other
69.46%
Mutual funds
0.00%
Foreign Institutional Investor (FII)
FII shareholding by period
Dec 20250.00%
Mar 20260.00%
Jun 20260.00%
Jul 20260.00%
Mkt Cap Cr
105.15
P/E
24.59
P/B
1.58
ROE
6.03%
D/E
0.27
ROCE
8.35%
Div. Yield
0.00%
EPS(TTM)
0.31
Turnover
0.88
EV/EBITDA
15.70
Net Margin
0.00%
Op. Margin
0.00%
ROA
3.45%
Quick Ratio
0.00
Curr. Ratio
3.22
Based on fundamentals, this stock's
Step 5 of 5
Performance
Excellent
Vaishali Pharma outperforming all market indices
Step 1 of 5
Valuation
Overvalued
Vaishali Pharma appears overvalued compared to its peers
Step 3 of 5
Earnings
Neutral
Vaishali Pharma earnings growth is positive
Peer Comparison
Peer comparison — key ratios
NameMkt Cap CrP/EP/BROED/EROCEBook ValueDiv. YieldTurnoverEPS(TTM)
Sun Pharmaceutical Industries4,63,791.0037.705.4713.74%0.6117.33%93.240.84%0.4810.90
Divis Laboratories2,45,081.0083.9114.6415.32%0.0019.56%629.490.32%0.5598.19
Torrent Pharmaceuticals1,90,351.0086.8922.2825.49%1.6913.85%222.760.69%0.4958.70
Zydus Lifesciences1,14,833.0024.654.1818.59%0.3117.35%237.300.09%0.3335.38
Cipla1,12,212.0033.443.2611.27%0.0014.95%423.360.94%0.4543.52
Laurus Labs1,01,155.0092.7719.0916.77%0.4016.14%97.200.11%0.6713.72
Lupin98,431.0017.594.3523.76%0.0424.88%659.000.84%0.57129.18
Mankind Pharma98,304.7046.845.9411.74%0.3413.13%396.980.04%0.4449.37
Dr. Reddy's Laboratories96,405.5030.282.5311.07%0.1812.54%377.950.69%0.4138.68
Aurobindo Pharma95,299.8025.232.479.25%0.1911.76%394.820.25%0.3841.58

Auto-generated based on historical fundamentals; not a recommendation to buy/sell.

Vaishali Pharma Financials

Full statement

Income Statement · Consolidated

Income Statement · Consolidated — all values in INR Crore
ParticularsMar 2026
Revenue112.61
Operating profit5.39
Net profit4.03

Income Statement · Standalone

Income Statement · Standalone — all values in INR Crore
ParticularsMar 2025Mar 2024Mar 2023Mar 2022
Revenue₹99.03₹86.28₹69.66₹75.82
Other Income₹3.21₹2.03₹2.23₹1.79
Total Revenue₹102.23₹88.31₹71.89₹77.61
Total Expenses₹101.01₹87.39₹63.05₹71.88
Profit Before Tax₹1.23₹0.93₹8.85₹5.73
Tax₹0.41₹0.21₹2.24₹1.70
Profit After Tax₹0.82₹0.72₹6.60₹4.02
EPS - Basic₹0.06₹0.68₹6.26₹3.82
EPS - Diluted₹0.06₹0.64₹5.91₹3.82

Cash Flow · Standalone

Cash Flow · Standalone — all values in INR Crore
ParticularsMar 2025Mar 2024Mar 2023Mar 2022
Profit before tax₹1.23₹0.93₹8.85₹5.73
Income before WC changes₹8.13₹6.78₹10.01₹7.35
Change in Assets-₹35.08₹2.54₹4.00₹7.09
Change in Liabilities₹9.26-₹6.23-₹11.36-₹12.29
Change in WC-₹25.82-₹3.70-₹7.36-₹5.20
Cash flow from Operations-₹18.04₹0.81₹1.08₹1.32
Cash flow from Investing-₹0.19₹1.20₹0.28-₹0.85
Cash flow from Financing₹18.49-₹1.42-₹1.73₹0.42
Total Cash Flow₹0.26₹0.59-₹0.37₹0.89
Cash (Start of the year)₹1.58₹0.98₹1.36₹0.47
Cash (End of the year)₹1.84₹1.58₹0.98₹1.36

Balance Sheet · Standalone

Balance Sheet · Standalone — all values in INR Crore
ParticularsMar 2025Mar 2024Mar 2023Mar 2022
Non-Current Assets₹5.36₹5.44₹6.23₹5.20
Current Assets₹104.48₹74.52₹72.67₹76.43
Total Assets₹109.84₹79.96₹78.90₹81.62
Current Liabilities₹40.05₹33.08₹32.07₹51.94
Net Current Asset₹64.43₹41.44₹40.60₹24.49
Non-Current Liabilities₹4.88₹4.03₹6.30₹3.33
Equity Capital₹64.92₹42.84₹40.53₹26.35
Total Equity & Liabilities₹109.84₹79.96₹78.90₹81.62
* All values are in INR Crore
Qty
Bid
95
8.44
200
8.4
1
8.36
3
8.3
3000
8.06
Ask
Qty
8.54
500
8.55
5000
8.6
250
8.79
6719
8.8
5000
Bid Total: 3299
Ask Total: 17469
Buy orders: 16%
Sell orders: 84%
Bearish
2
Neutral
5
Bullish
1
Slightly Bearish
by SEBI experts
Expert Pick
EXPPICK
Stop-loss
Entry price
Target
Indicator
Value
Verdict
RSI (14)
58.55
Neutral
ATR (14)
0.47
Neutral
STOCH(9,6)
83.56
Bearish
STOCH RSI (14)
57.4
Neutral
ADX(9)
14.05
Bullish
UO(9)
49.39
Neutral
ROC(12)
-0.59
Bearish
WillR(14)
-44.55
Neutral
Period
Simple value
Exponential vaue
5D
8.16
8.19
10D
8.14
8.17
20D
8.2
8.11
50D
7.84
7.89
100D
7.6
7.73
Volume trend — traded volume by day
3 Sep0L
2 Sep0L
1 Sep1L
31 Aug0L
28 Aug0L
Average1L

Technical indicators used here are for indicative purposes only. Kindly do not treat it as an investment or trading advice

Compare against other stocks
Vaishali Pharma Share Price
Vaishali Pharma
Pharmaceuticals
Add Stock
Add Another

Vaishali Pharma Share Price FAQs

Vaishali Pharma share price data is sourced from NSE/BSE and may be delayed. It is displayed for informational purposes only and does not constitute investment advice or a recommendation to buy or sell.

Trusted by 2 Crore+ Indians for their wealth-building needs. SEBI Registered Broker. SEBI Reg No. INZ000315837